In acute ischemic stroke
Links to stroke information and organizations

Genentech is neither affiliated with nor endorses the following organizations.

American Stroke Association (ASA)
www.strokeassociation.org
The ASA is a division of the American Heart Association. It focuses on "reducing disability and death from stroke through research, education, fundraising, and advocacy." The ASA Web site offers vital information about stroke, including warning signs, general facts, and treatment. The site also provides resources such as a multimedia stroke library, The Heart and Stroke Encyclopedia, educational materials, and a free subscription to Stroke Connection magazine.

National Stroke Association (NSA)
www.stroke.org
The NSA, established in 1984, is the only national nonprofit organization in the United States specifically dedicated to reducing the incidence and impact of stroke. The NSA provides education and other services committed to the prevention, treatment, rehabilitation, and recovery of stroke. On the Web site, patients can find answers to frequently asked questions, tips on prevention, and other facts about stroke. Materials are also available in French and Spanish. In addition, the NSA Web site offers a number of resources for family members of stroke victims.

The Stroke Information Directory (SID)
www.stroke-info.com
SID was started in the mid-1980s by family members of stroke survivors to assist patients, their families, clinicians, and researchers with locating stroke information online. The Web site houses links to a wide number of stroke-specific sites that are helpful for patients and their families. The site also offers fact sheets that address a variety of stroke-related issues, as well as interactive tools such as the Facility Finder, which can be used to locate stroke treatment providers in your region.

Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography (CT) scan or other diagnostic imaging method sensitive for the presence of hemorrhage (see CONTRAINDICATIONS in the full prescribing information).

Safety Information: All thrombolytic agents increase the risk of bleeding, including intracranial bleeding, and should be used only in appropriate patients. Not all patients with acute ischemic stroke will be eligible for Activase therapy, including patients with evidence of recent or active bleeding; recent (within 3 months) intracranial or intraspinal surgery, serious head trauma, or previous stroke; uncontrolled high blood pressure; or impaired blood clotting.


Please see full prescribing information.


Site MapImportant Safety InformationAdditional IndicationPrescribing InformationCopyrightTerms and ConditionsPrivacy PolicyContact Us
The information contained in this site is intended for US residents only.